Inherited Retinal Degenerative Disease Registry
Public ClinicalTrials.gov record NCT02435940. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Foundation Fighting Blindness My Retina Tracker Registry
Study identification
- NCT ID
- NCT02435940
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Foundation Fighting Blindness
- Other
- Enrollment
- 20,000 participants
Conditions and interventions
Conditions
- Achromatopsia
- Bardet-Biedl Syndrome
- Bassen-Kornzweig Syndrome
- Batten Disease
- Best Disease
- Choroidal Dystrophy
- Choroideremia
- Cone Dystrophy
- Cone-Rod Dystrophy
- Congenital Stationary Night Blindness
- Enhanced S-Cone Syndrome
- Eye Diseases Hereditary
- Fundus Albipunctatus
- Goldmann-Favre Syndrome
- Gyrate Atrophy
- Juvenile Macular Degeneration
- Kearns-Sayre Syndrome
- Leber Congenital Amaurosis
- Refsum Syndrome
- Retinal Disease
- Retinitis Pigmentosa
- Retinitis Punctata Albescens
- Retinoschisis
- Rod Dystrophy
- Rod Monochromacy
- Rod-Cone Dystrophy
- Stargardt Disease
- Usher Syndrome
Interventions
Not listed
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2014
- Primary completion
- May 31, 2037
- Completion
- May 31, 2037
- Last update posted
- May 18, 2026
2014 – 2037
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Foundation Fighting Blindness | Columbia | Maryland | 21045 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02435940, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 18, 2026 · Synced May 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02435940 live on ClinicalTrials.gov.